Safinamide Improves Non-Motor Symptoms Burden in Parkinson’s Disease: An Open-Label Prospective Study

Safinamide Improves Non-Motor Symptoms Burden in Parkinson’s Disease: An Open-Label Prospective Study

Some studies observed a benefit of Parkinson´s disease (PD) patients after treatment with safinamide in some non-motor symptoms (NMSs). The aim of this study was to analyze the effectiveness of safinamide on NMS burden in PD. SAFINONMOTOR (an open-label study of the effectiveness of safinamide on no...

Full description

Bibliographic Details
Main Authors: Diego Santos García, Carmen Labandeira Guerra, Rosa Yáñez Baña, Maria Icíar Cimas Hernando, Iria Cabo López, Jose Manuel Paz Gonález, Maria Gemma Alonso Losada, María José González Palmás, Cristina Martínez Miró
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Brain Sciences
Subjects:
effectiveness
non-motor symptoms
open-label study
Parkinson´s disease
safinamide
Online Access:https://www.mdpi.com/2076-3425/11/3/316

Internet

https://www.mdpi.com/2076-3425/11/3/316

Similar Items